Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

BMS-777607, a Small-Molecule Met Kinase Inhibitor, Suppresses Hepatocyte Growth Factor–Stimulated Prostate Cancer Metastatic Phenotype In vitro

Mol Cancer Ther (2010) 9 (6): 1554–1561.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Rh‐Catalyzed Chemodivergent [3+3] Annulations of Diazoenals and α‐Aminoketones: Direct Synthesis of Functionalized 1,2‐Dihydropyridines and Fused 1,4‐Oxazines
  • Pratap Kumar Mandal
  • Sreenivas Katukojvala
Chemistry – A European Journal (2024) 30 (19)
A computer-aided drug design approach to explore novel type II inhibitors of c-Met receptor tyrosine kinase for cancer therapy: QSAR, molecular docking, ADMET and molecular dynamics simulations
  • Ossama Daoui
  • Hassan Nour
  • Oussama Abchir
  • Souad Elkhattabi
  • Mohamed Bakhouch
  • Samir Chtita
Journal of Biomolecular Structure and Dynamics (2023) 41 (16): 7768.
Strategies for Managing Solid Form Transformation Risk in Drug Product
  • Umesh Kestur
  • Anisha Patel
  • Sherif Badawy
  • Neil Mathias
  • Limin Zhang
Journal of Pharmaceutical Sciences (2023) 112 (4): 909.
Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer
  • Rumeysa Ozyurt
  • Bulent Ozpolat
Molecular Cancer Therapeutics (2023) 22 (7): 818.
New pyrazolopyridine and pyrazolothiazole-based compounds as anti-proliferative agents targeting c-Met kinase inhibition: design, synthesis, biological evaluation, and computational studies
  • Zahra M. Alamshany
  • Eman M. Algamdi
  • Ismail M. M. Othman
  • Manal M. Anwar
  • Eman S. Nossier
RSC Advances (2023) 13 (19): 12889.
The mystery of titan hunter: Rationalized striking of the MAPK pathway via Newly synthesized 6‐Indolylpyridone‐3‐Carbonitrile derivatives
  • Mohamed M. Saleh
  • Tarek El-Moselhy
  • Eman El-Bastawissy
  • Mahmoud A.A. Ibrahim
  • Shaban R.M. Sayed
  • Mohamed-Elamir F. Hegazy
  • Thomas Efferth
  • Laila A. Jaragh-Alhadad
  • Peter A. Sidhom
European Journal of Medicinal Chemistry (2023) 259: 115675.
Identification of (S)-1-(2-(2,4-difluorophenyl)-4-oxothiazolidin-3-yl)-3-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)urea as a potential anti-colorectal cancer agent
  • Baohui Qi
  • Fei Wang
  • Huan He
  • Mengmeng Fan
  • Liping Hu
  • Li Xiong
  • Guowei Gong
  • Shengmin Shi
  • Xiaomeng Song
European Journal of Medicinal Chemistry (2022) 239: 114561.
Discovery of novel conjugates of quinoline and thiazolidinone urea as potential anti-colorectal cancer agent
  • Li Xiong
  • Huan He
  • Mengmeng Fan
  • Liping Hu
  • Fei Wang
  • Xiaomeng Song
  • Shengmin Shi
  • Baohui Qi
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) 37 (1): 2334.
AXL kinase inhibitors- A prospective model for medicinal chemistry strategies in anticancer drug discovery
  • Chinmay Malvankar
  • Dileep Kumar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) 1877 (5): 188786.
Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
  • Jakob Shoti
  • Keyun Qing
  • Arun Srivastava
Frontiers in Microbiology (2022) 13
Novel 4-phenoxypyridine derivatives bearing imidazole-4-carboxamide and 1,2,4-triazole-3-carboxamide moieties: Design, synthesis and biological evaluation as potent antitumor agents
  • Ju Liu
  • Fang Liu
  • Zhen Li
  • Chunyan Li
  • Shuang Wu
  • Jiwei Shen
  • Huan Wang
  • Siyuan Du
  • Hao Wei
  • Yunlei Hou
  • Shi Ding
  • Ye Chen
Bioorganic Chemistry (2022) 120: 105629.
From Therapy Resistance to Targeted Therapies in Prostate Cancer
  • Filipa Moreira-Silva
  • Rui Henrique
  • Carmen Jerónimo
Frontiers in Oncology (2022) 12
Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer
  • Mai Tanaka
  • Dietmar W. Siemann
International Journal of Molecular Sciences (2021) 22 (18): 9953.
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
  • Osama M. Soltan
  • Mai E. Shoman
  • Salah A. Abdel-Aziz
  • Atsushi Narumi
  • Hiroyuki Konno
  • Mohamed Abdel-Aziz
European Journal of Medicinal Chemistry (2021) 225: 113768.
Targeting AXL in NSCLC
  • Aubhishek Zaman
  • Trever G Bivona
Lung Cancer: Targets and Therapy (2021) Volume 12: 67.
Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells
  • Sun Tae Hwang
  • Jae-Young Um
  • Arunachalam Chinnathambi
  • Sulaiman Ali Alharbi
  • Acharan S. Narula
  • Ojas A. Namjoshi
  • Bruce E. Blough
  • Kwang Seok Ahn
Molecules (2020) 25 (6): 1320.
Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors
  • Jun Li
  • Jie Li
  • Jiaojiao Zhang
  • Jiantao Shi
  • Shi Ding
  • Yajing Liu
  • Ye Chen
  • Ju Liu
Anti-Cancer Agents in Medicinal Chemistry (2020) 20 (5): 559.
A Low Cost Sensitive Transrectal Photoacoustic Probe With Single-Fiber Bright-Field Illumination for In Vivo Canine Prostate Imaging and Real-Time Biopsy Needle Guidance
  • Bing Cong
  • Chen Qiu
  • Yaguang Ren
  • Yuanyuan Bai
  • Muyue Xing
  • Tinghui Yin
  • Xiaojing Gong
  • Liang Song
  • Rongqin Zheng
  • Chengbo Liu
IEEE Sensors Journal (2020) 20 (18): 10974.
Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors
  • Ju Liu
  • Yilin Gong
  • Jiantao Shi
  • Xuechen Hao
  • Yang Wang
  • Yunpeng Zhou
  • Yunlei Hou
  • Yajing Liu
  • Shi Ding
  • Ye Chen
European Journal of Medicinal Chemistry (2020) 194: 112244.
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
  • Justus M. Huelse
  • Diana M. Fridlyand
  • Shelton Earp
  • Deborah DeRyckere
  • Douglas K. Graham
Pharmacology & Therapeutics (2020) 213: 107577.
Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors
  • Zhen Wang
  • Jiantao Shi
  • Xianglong Zhu
  • Wenwen Zhao
  • Yilin Gong
  • Xuechen Hao
  • Yunlei Hou
  • Yajing Liu
  • Shi Ding
  • Ju Liu
  • Ye Chen
Bioorganic Chemistry (2020) 105: 104371.
In vivo transrectal imaging of canine prostate with a sensitive and compact handheld transrectal array photoacoustic probe for early diagnosis of prostate cancer
  • Chengbo Liu
  • Muyue Xing
  • Bing Cong
  • Chen Qiu
  • Dong He
  • Congzhi Wang
  • Yang Xiao
  • Tinghui Yin
  • Min Shao
  • Weibao Qiu
  • Teng Ma
  • Xiaojing Gong
  • Xiong Chen
  • Hairong Zheng
  • Rongqin Zheng
  • Liang Song
Biomedical Optics Express (2019) 10 (4): 1707.
Phosphatidylserine receptor-targeting therapies for the treatment of cancer
  • Miso Park
  • Keon Wook Kang
Archives of Pharmacal Research (2019) 42 (7): 617.
Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
  • Pei-Wen Yang
  • Yu-Cheng Liu
  • Ya-Han Chang
  • Ching-Ching Lin
  • Pei-Ming Huang
  • Kuo-Tai Hua
  • Jang-Ming Lee
  • Min-Shu Hsieh
Frontiers in Oncology (2019) 9
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
  • Chenjing Zhu
  • Yuquan Wei
  • Xiawei Wei
Molecular Cancer (2019) 18 (1)
Therapeutic Inducers of Apoptosis in Ovarian Cancer
  • Mudra Binju
  • Monica Angelica Amaya-Padilla
  • Graeme Wan
  • Hendra Gunosewoyo
  • Yohan Suryo Rahmanto
  • Yu Yu
Cancers (2019) 11 (11): 1786.
Antitumor effects of BMS-777607 on ovarian cancer cells with constitutively activated c-MET
  • Chao-Chih Wu
  • Chia-Sui Weng
  • Yun-Ting Hsu
  • Chih-Long Chang
Taiwanese Journal of Obstetrics and Gynecology (2019) 58 (1): 145.
Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion
  • Veronica S. Hughes
  • Dietmar W. Siemann
Oncotarget (2019) 10 (2): 184.
TYRO3: A potential therapeutic target in cancer
  • Pei-Ling Hsu
  • Jonathan Jou
  • Shaw-Jenq Tsai
Experimental Biology and Medicine (2019) 244 (2): 83.
Axl signaling is an important mediator of tumor angiogenesis
  • Mai Tanaka
  • Dietmar W. Siemann
Oncotarget (2019) 10 (30): 2887.
Synthesis of Pyridine-Dicarboxamide-Cyclohexanone Derivatives: Anticancer and α-Glucosidase Inhibitory Activities and In Silico Study
  • Abdullah Mohammed Al-Majid
  • Mohammad Shahidul Islam
  • Saleh Atef
  • Fardous F. El-Senduny
  • Farid A. Badria
  • Yaseen A. M. M. Elshaier
  • M. Ali
  • Assem Barakat
  • A. F. M. Motiur Rahman
Molecules (2019) 24 (7): 1332.
Axl inhibitors as novel cancer therapeutic agents
  • Yingying Shen
  • Xiguang Chen
  • Jun He
  • Duanfang Liao
  • Xuyu Zu
Life Sciences (2018) 198: 99.
Synthesis and biological evaluation of 4-(2-fluorophenoxy)-3,3′-bipyridine derivatives as potential c-met inhibitors
  • Sijia Zhao
  • Yu Zhang
  • Hongyang Zhou
  • Shuancheng Xi
  • Bin Zou
  • Guanglong Bao
  • Limei Wang
  • Jiao Wang
  • Tianfang Zeng
  • Ping Gong
  • Xin Zhai
European Journal of Medicinal Chemistry (2016) 120: 37.
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: ‘Game Over’?
  • Alessandra Modena
  • Francesco Massari
  • Chiara Ciccarese
  • Matteo Brunelli
  • Matteo Santoni
  • Rodolfo Montironi
  • Guido Martignoni
  • Giampaolo Tortora
Targeted Oncology (2016) 11 (4): 431.
RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers
  • Najme Faham
  • Alana L. Welm
Cold Spring Harbor Symposia on Quantitative Biology (2016) 81: 177.
MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer
  • Cristina Pérez-Ramírez
  • Marisa Cañadas-Garre
  • Miguel Ángel Molina
  • María José Faus-Dáder
  • Miguel Ángel Calleja-Hernández
Pharmacological Research (2015) 102: 90.
A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts
  • Yanlan Yu
  • Yicheng Chen
  • Guoqing Ding
  • Mingchao Wang
  • Haiyang Wu
  • Liwei Xu
  • Xuefang Rui
  • Zhigen Zhang
Biochemical and Biophysical Research Communications (2015) 464 (1): 154.
Synergistic Activities of MET/RON Inhibitor BMS-777607 and mTOR Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells
  • Jun-Ying Zeng
  • Sharad Sharma
  • Yong-Qing Zhou
  • Hang-Ping Yao
  • Xing Hu
  • Ruiwen Zhang
  • Ming-Hai Wang
Molecular Cancer Therapeutics (2014) 13 (1): 37.
Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue
  • Daniel V. T. Catenacci
  • Wei-Li Liao
  • Sheeno Thyparambil
  • Les Henderson
  • Peng Xu
  • Lei Zhao
  • Brittany Rambo
  • John Hart
  • Shu-Yuan Xiao
  • Kathleen Bengali
  • Jamar Uzzell
  • Marlene Darfler
  • David B. Krizman
  • Fabiola Cecchi
  • Donald P. Bottaro
  • Theodore Karrison
  • Timothy D. Veenstra
  • Todd Hembrough
  • Jon Burrows
  • Valli De Re
PLoS ONE (2014) 9 (7): e100586.
Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo
  • Yuan-hui Zhang
  • Yuan Wang
  • Ali Hussein Yusufali
  • Frederick Ashby
  • Daniel Zhang
  • Zi-fei Yin
  • George V. Aslanidi
  • Arun Srivastava
  • Chang-quan Ling
  • Chen Ling
Journal of Integrative Medicine (2014) 12 (6): 483.
Cabozantinib Inhibits Prostate Cancer Growth and Prevents Tumor-Induced Bone Lesions
  • Jinlu Dai
  • Honglai Zhang
  • Andreas Karatsinides
  • Jill M. Keller
  • Kenneth M. Kozloff
  • Dana T. Aftab
  • Frauke Schimmoller
  • Evan T. Keller
Clinical Cancer Research (2014) 20 (3): 617.
SelectiveIn VivoTargeting of Human Liver Tumors by Optimized AAV3 Vectors in a Murine Xenograft Model
  • Chen Ling
  • Yuan Wang
  • Yuanhui Zhang
  • Anila Ejjigani
  • Zifei Yin
  • Yuan Lu
  • Lina Wang
  • Meng Wang
  • Jun Li
  • Zhongbo Hu
  • George V. Aslanidi
  • Li Zhong
  • Guangping Gao
  • Arun Srivastava
  • Changquan Ling
Human Gene Therapy (2014) 25 (12): 1023.
Prevention of BMS‐777607‐induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics
  • Sharad Sharma
  • Hang-Ping Yao
  • Yong-Qing Zhou
  • Jianwei Zhou
  • Ruiwen Zhang
  • Ming-Hai Wang
Molecular Oncology (2014) 8 (3): 469.
New aminopyrimidine derivatives as inhibitors of the TAM family
  • Ténin Traoré
  • Andrea Cavagnino
  • Nicolas Saettel
  • François Radvanyi
  • Sandrine Piguel
  • Isabelle Bernard-Pierrot
  • Véronique Stoven
  • Michel Legraverend
European Journal of Medicinal Chemistry (2013) 70: 789.
Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents
  • Sharad Sharma
  • Jun-Ying Zeng
  • Chun-Mei Zhuang
  • Yong-Qing Zhou
  • Hang-Ping Yao
  • Xing Hu
  • Ruiwen Zhang
  • Ming-Hai Wang
Molecular Cancer Therapeutics (2013) 12 (5): 725.
Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling
  • Holly M. Nguyen
  • Nazanin Ruppender
  • Xiaotun Zhang
  • Lisha G. Brown
  • Ted S. Gross
  • Colm Morrissey
  • Roman Gulati
  • Robert L. Vessella
  • Frauke Schimmoller
  • Dana T. Aftab
  • Eva Corey
  • Daotai Nie
PLoS ONE (2013) 8 (10): e78881.
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma
  • G.T. Gibney
  • S.A. Aziz
  • R.L. Camp
  • P. Conrad
  • B.E. Schwartz
  • C.R. Chen
  • W.K. Kelly
  • H.M. Kluger
Annals of Oncology (2013) 24 (2): 343.
Extracellular Alkaline pH Leads to Increased Metastatic Potential of Estrogen Receptor Silenced Endocrine Resistant Breast Cancer Cells
  • Maitham A. Khajah
  • Iman Almohri
  • Princy M. Mathew
  • Yunus A. Luqmani
  • Chih-Hsin Tang
PLoS ONE (2013) 8 (10): e76327.
Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer
  • Neeraj Agarwal
  • Guru Sonpavde
  • Cora N. Sternberg
European Urology (2012) 61 (5): 950.
The RON‐receptor regulates pancreatic cancer cell migration through phosphorylation‐dependent breakdown of the hemidesmosome
  • Peter T. Yu
  • Michele Babicky
  • Dawn Jaquish
  • Randy French
  • Karly Marayuma
  • Evangeline Mose
  • Sherry Niessen
  • Heather Hoover
  • David Shields
  • David Cheresh
  • Benjamin F. Cravatt
  • Andrew M. Lowy
International Journal of Cancer (2012) 131 (8): 1744.
  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept